BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8033172)

  • 1. Technetium-labeled myocardial perfusion agents.
    Heo J; Iskandrian AS
    Cardiol Clin; 1994 May; 12(2):187-98. PubMed ID: 8033172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of cardiac imaging with sestamibi and teboroxime.
    Leppo JA; DePuey EG; Johnson LL
    J Nucl Med; 1991 Oct; 32(10):2012-22. PubMed ID: 1833519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial perfusion imaging with technetium-99m-labeled agents.
    Maddahi J; Kiat H; Berman DS
    Am J Cardiol; 1991 May; 67(14):27D-34D. PubMed ID: 1827941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS; Kiat H; Maddahi J
    Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial perfusion imaging using single-photon emission computed tomography.
    Garvin AA; Cullom SJ; Garcia EV
    Am J Card Imaging; 1994 Apr; 8(2):189-98. PubMed ID: 8032191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
    Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J
    Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New agents labelled with technetium 99m for myocardial perfusion imaging.
    Taillefer R
    Can Assoc Radiol J; 1992 Aug; 43(4):258-66. PubMed ID: 1386280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion imaging in ischemic heart disease.
    Rivitz SM; Deluca SA
    Am Fam Physician; 1993 Nov; 48(6):1071-8. PubMed ID: 8237730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-isotope myocardial perfusion SPECT with rest thallium-201 and stress Tc-99m sestamibi.
    Berman DS; Kiat H; Van Train K; Friedman JD; Wang FP; Germano G
    Cardiol Clin; 1994 May; 12(2):261-70. PubMed ID: 8033176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
    Meerdink DJ; Leppo JA
    Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.
    Maddahi J; Kiat H; Van Train KF; Prigent F; Friedman J; Garcia EV; Alazraki N; DePuey EG; Nichols K; Berman DS
    Am J Cardiol; 1990 Oct; 66(13):55E-62E. PubMed ID: 2145748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in myocardial perfusion imaging: 99mTc-teboroxime.
    Pieri PL; Strauss HW
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):22-8. PubMed ID: 1450239
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease.
    Taillefer R; Lambert R; Essiambre R; Phaneuf DC; Léveillé J
    J Nucl Med; 1992 Jun; 33(6):1091-8. PubMed ID: 1534575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent.
    Johnson LL; Seldin DW
    Am J Cardiol; 1990 Oct; 66(13):63E-67E. PubMed ID: 2220625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary report of SPECT imaging with Tc-99m teboroxime in ischemic heart disease.
    Drane WE; Keim S; Strickland P; Tineo A; Nicole M
    Clin Nucl Med; 1992 Mar; 17(3):215-25. PubMed ID: 1611794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction--Technetium-99m myocardial perfusion imaging agents and their relation to thallium-201.
    Berman DS
    Am J Cardiol; 1990 Oct; 66(13):1E-4E. PubMed ID: 1977298
    [No Abstract]   [Full Text] [Related]  

  • 17. Tomographic myocardial perfusion imaging with technetium-99m teboroxime during adenosine-induced coronary hyperemia: correlation with thallium-201 imaging.
    Iskandrian AS; Heo J; Nguyen T; Beer S; Cave V; Cassel D; Iskandrian BB
    J Am Coll Cardiol; 1992 Feb; 19(2):307-12. PubMed ID: 1732357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of technetium-99m teboroxime tomography with automated quantitative coronary arteriography and thallium-201 tomographic imaging.
    Fleming RM; Kirkeeide RL; Taegtmeyer H; Adyanthaya A; Cassidy DB; Goldstein RA
    J Am Coll Cardiol; 1991 May; 17(6):1297-302. PubMed ID: 2016447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
    Beller GA; Watson DD
    Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m sestamibi in chronic coronary artery disease: the European experience.
    Sochor H
    Am J Cardiol; 1990 Oct; 66(13):91E-96E. PubMed ID: 2145754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.